Equitec Proprietary Markets’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Equitec Proprietary Markets’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,400	Closed	-$74.3K	–	122
2023 Q4	$74.3K	Buy	+7,400	New	+$33.6K	0.06%	48

Equitec Proprietary Markets's GRCL Position: Q1 2024 in Review

Equitec Proprietary Markets sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 7,400 shares — an estimated $74.3K sold.

Equitec Proprietary Markets first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $74.3K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Equitec Proprietary Markets reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Equitec Proprietary Markets sold 7,400 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $74.3K.
Equitec Proprietary Markets first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Equitec Proprietary Markets's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $74.3K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Equitec Proprietary Markets's 13F filing for Q1 2024, filed 26 Apr 2024.